(from asco 2011) video: Dr Steven Joffe – Dana-Farber Cancer Institute, Boston - Ethics of early-phase clinical trials on ecancer tv. Cancer journal: online cancer news, clinical oncology research, cancer information and latest cancer studies - open access cancer journal: ecancermedicalscience Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, June 17, 2011

(from asco 2011) video: Dr Steven Joffe – Dana-Farber Cancer Institute, Boston - Ethics of early-phase clinical trials on ecancer tv. Cancer journal: online cancer news, clinical oncology research, cancer information and latest cancer studies - open access cancer journal: ecancermedicalscience



Ethics of early-phase clinical trials
Dr Joffe talks to ecancer tv at ASCO 2011 about the arguments around patient recruitment and expectation management in early-phase clinical trials.

1 comment :

  1. I saw his lecture in person at ASCO. While listening I couldn't help but think that the perception of when to enroll in clinical trials needs to change. Most people think of it as the last resort. I was offered and enrolled in a phase I clinical trial when I was initially treated for ovarian cancer in 2005 . I knew that what I was taking was not going to be looked at in terms of benefit to me but rather the best level for future testing.I read about the agent and its use with other cancers and I figured if it wasn't going to hurt me why not take it. Sure it meant extra blood draws and visits to the clinic but I looked at that as a bonus since I had extra people watching and responding to what was happening to me.

    ReplyDelete

Your comments?

Note: Only a member of this blog may post a comment.

1 comment :

  1. I saw his lecture in person at ASCO. While listening I couldn't help but think that the perception of when to enroll in clinical trials needs to change. Most people think of it as the last resort. I was offered and enrolled in a phase I clinical trial when I was initially treated for ovarian cancer in 2005 . I knew that what I was taking was not going to be looked at in terms of benefit to me but rather the best level for future testing.I read about the agent and its use with other cancers and I figured if it wasn't going to hurt me why not take it. Sure it meant extra blood draws and visits to the clinic but I looked at that as a bonus since I had extra people watching and responding to what was happening to me.

    ReplyDelete

Your comments?

Note: Only a member of this blog may post a comment.